zolmitriptano farmoz 25 mg comprimido orodispersível - search results

zydus lifesciences limited - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. - zolmitriptan tablets are not indicated for the prevention of migraine attacks. - safety and effectiveness of zolmitriptan have not been established for cluster - headache. zolmitriptan tablets are contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal's angina [see warnings and precautions (5.1) ] - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see

United States - English - NLM (National Library of Medicine)

zolmitriptan tablet, film coated

zydus pharmaceuticals usa inc. - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. - zolmitriptan tablets are not indicated for the prevention of migraine attacks. - safety and effectiveness of zolmitriptan have not been established for cluster - headache. zolmitriptan tablets are contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal's angina [see warnings and precautions (5.1) ] - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see

United States - English - NLM (National Library of Medicine)

zolmitriptan tablet, film coated

ingenus pharmaceuticals, llc - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan tabletsare indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan tablets if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. - zolmitriptan tablets are not indicated for the prevention of migraine attacks. - safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. zolmitriptan is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or c oronary artery vasospasm including prinzmetal’s angina [see warnings and precautions (5.1) ] - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zolmitriptan 2.5mg tablets

torrent pharma (uk) ltd - zolmitriptan - oral tablet - 2.5mg